scholarly article | Q13442814 |
P356 | DOI | 10.1097/00004714-199202001-00008 |
P698 | PubMed publication ID | 1541718 |
P2093 | author name string | J. R. Calabrese | |
P. J. Markovitz | |||
S. C. Wagner | |||
S. E. Kimmel | |||
P433 | issue | 1 Suppl | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 53S-56S | |
P577 | publication date | 1992-02-01 | |
P1433 | published in | Journal of Clinical Psychopharmacology | Q6294969 |
P1476 | title | Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients | |
P478 | volume | 12 |
Q34237178 | A review of bipolar disorder in adults |
Q42645137 | An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization |
Q35664266 | Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians |
Q35017636 | Bipolar depression: management options |
Q43641257 | CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity |
Q40866452 | Continuation and maintenance pharmacotherapy for unipolar and bipolar mood disorders. |
Q39410022 | Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression |
Q36398195 | Dose-dependent valproate-induced alopecia in patients with mental disorders |
Q44266754 | Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients |
Q72561737 | Effects of chronic treatment with valproate on serotonin-1A receptor binding and function |
Q35101178 | Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects |
Q34034322 | Efficacy and tolerability of injectable sodium valproate in patients with mania |
Q34185305 | Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review |
Q33938089 | Impact of substance abuse on the course and treatment of bipolar disorder |
Q36233958 | Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study |
Q36806521 | Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder |
Q34762525 | Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? |
Q44266760 | Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling |
Q34508138 | Pharmacologic treatment of geriatric mania |
Q47642128 | The Black Book of Psychotropic Dosing and Monitoring |
Q34185336 | The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence |
Q33878237 | The role of gender in mixed mania |
Q40866426 | Treatment of acute mania. |
Q34832733 | Treatment of bipolar disorder in older adults |
Q33922181 | Treatment of bipolar mixed state with olanzapine. |
Q35142736 | Valproate |
Q22252976 | Valproate for acute mood episodes in bipolar disorder |
Q48305334 | Valproate robustly enhances AP-1 mediated gene expression |
Q73628831 | Valproate treatment and the risk of hyperandrogenism and polycystic ovaries |
Q58570012 | Valproate: It's Effects on Hair |
Q35171196 | Valproate: past, present, and future. |
Q79351350 | [Bipolar depression: a review of current therapeutic strategies] |
Search more.